FitLife Brands, Inc. (FTLF) AI Stock Analysis

FitLife Brands, Inc. specializes in providing nutritional supplements tailored for health-conscious consumers across the United States and global markets. Its product line includes weight loss supplements, general health formulations, and sports nutrition products designed for diverse dietary and fitness needs. The company also offers precision sports nutrition formulations for muscular development, performance enhancers, and men's health formulations. FitLife Brands markets its products under brand names including NDS Nutrition, PMD Sports, SirenLabs, CoreActive, Metis Nutrition, iSatori, BioGenetic Laboratories, and Energize, distributing through franchised stores, specialty shops, mass retailers, and online platforms.

FitLife Brands grew annual revenue from $27.9M in FY2021 to $81.5M in FY2025, recording a 5-year revenue CAGR of 30.2%. Top-line revenue increased 26.4% in FY2025, following growth of 22.3% in FY2024 and 83.0% in FY2023. Gross margin stood at 38.6% in FY2025, down from 43.6% in FY2024 and 44.8% in FY2021. Net income reached $6.3M in FY2025 with a net margin of 7.8%, after reporting $9.0M in FY2024. For the trailing twelve months ending June 30, 2026, revenue totaled $101.3M with a profit margin of 6.2%. In the latest quarter ended June 30, 2026, quarterly revenue grew 64.6% year-over-year while quarterly earnings rose 11.1%.

As of June 30, 2026, FitLife Brands held cash and short-term investments of $1.1M and total debt of $38.4M, resulting in net debt of $37.3M. The company reported a debt-to-equity ratio of 0.81, a current ratio of 1.46, total assets of $102.6M, and shareholders' equity of $47.4M. During FY2025, operating cash flow and free cash flow both stood at $7.4M, with capital expenditures of $42,000. Over a 5-year period, share count expanded 120.0%.

FitLife Brands trades at a trailing P/E of 13.5x and a forward P/E of 7.3x, both below the median of its US-listed Consumer Defensive peers at 18.6x and 14.3x, respectively. Its EV to EBITDA ratio is 10.5x compared to the peer median of 11.7x, while its price-to-sales ratio is 0.8x compared to the peer median of 0.7x. The company carries a market cap of $78.8M and an enterprise value of $125.8M. Over the past year, the stock fell 55.1%, trailing the S&P 500 (SPY) return of 16.8%.

FitLife Brands has 2 Strong Buy ratings, 0 Buy, 0 Hold, 0 Sell, and 0 Strong Sell ratings. The mean price target is $17.50, representing a 108.6% premium over the last close of $8.39. For the fiscal year ending December 31, 2026, consensus estimates project revenue of $105.9M and EPS of $0.87. For the following fiscal year, 1 analyst projects revenue of $112.6M and EPS of $1.29. The company beat EPS estimates in 2 of the last 4 quarters, with its next earnings date scheduled for November 12, 2026.

This page is an AI-written research summary of FitLife Brands, Inc. (FTLF). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.

Related: FTLF income statement, FTLF balance sheet, FTLF key metrics, FTLF analyst forecast, FTLF chart. See the FTLF stock overview for the latest quote and news.